Primary destination indicator is survival, secondary indicators include tumor response rate, symptoms improvement, weight change and liver function improvement.
首要终点指标是生存期，次要指标包括肿瘤缓解、症状改善、体重变化、肝功能改善等。
The response rate to erlotinib therapy was similar in patients with tumor-only mutations and in those with tumor and serum mutations (67%).
对埃罗替尼治疗的反应率，仅在肿瘤组织中存在变异的患者和那些肿瘤和血浆中均存在变异的患者是相似的(67%)。
The response rate (RR), the clinical benefit rate (CBR), time of tumor progression (TTP) and the quality of life (QOL) were observed.
观察有效率(RR)、临床受益率(CBR)、肿瘤进展时间(TTP)、生活质量(QOL)及不良反应。
The response rate (RR), the clinical benefit rate (CBR), time of tumor progression (TTP) and the quality of life (QOL) were observed.
观察有效率(RR)、临床受益率(CBR)、肿瘤进展时间(TTP)、生活质量(QOL)及不良反应。
应用推荐